Science Explorer Interactive view Map
Company · South San Francisco · United States

Principia Biopharma (United States)

principiabio.comROR OpenAlex
Research works
29
▼ 50% vs 2013–17
Citations
831
28.3 per fractional work
Top-10% rate
30.9%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: Principia Biopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Principia Biopharma (United States)?

Ranked on the composite score, David Goldstein lead among researchers whose main affiliation is Principia Biopharma (United States).

  1. 1 David Goldstein United States · #234,164 worldwide 74 citations · 27 works
All ranked researchers at Principia Biopharma (United States)

Which keywords describe research at Principia Biopharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Cancer, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Metabolism, Signaling and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Rituximab6▲ 122×3 topics
  2. Cancer5▲ 12×11 topics
  3. Prognostic Factors4▲ 29×3 topics
  4. Epidemiology4▲ 3.0×9 topics
  5. Chronic Lymphocytic Leukemia4▲ 242×1 topic
  6. Genomic Aberrations4▲ 242×1 topic
  7. Metabolism3▲ 14×3 topics
  8. Signaling3▲ 81×2 topics
  9. Obesity2▲ 10×2 topics
  10. FGF212▲ 472×1 topic
  11. Fibroblast Growth Factor2▲ 472×1 topic
  12. Immunosuppressive Therapy2▲ 38×2 topics
  13. Autoantibodies2▲ 27×2 topics
  14. Diagnosis2▲ 6.2×2 topics
  15. Bullous Pemphigoid2▲ 229×1 topic
  16. Pemphigoid2▲ 229×1 topic
  17. Tumor Microenvironment2▲ 17×4 topics
  18. Inflammation2▲ 2.4×9 topics
  19. HIF-11▲ 57×1 topic
  20. Warburg Effect1▲ 57×1 topic
  21. BCR-ABL1▲ 134×1 topic
  22. Imatinib1▲ 134×1 topic
  23. Cell Proliferation1▲ 38×3 topics
  24. DNA Methylation1▲ 30×2 topics
  25. Epigenetic Reprogramming1▲ 43×1 topic
  26. Histone Modification1▲ 52×1 topic

Which research topics does Principia Biopharma (United States) publish most on?

By volume in 2022–2025: Hippo pathway signaling and YAP/TAZ, Chronic Lymphocytic Leukemia Research, Ubiquitin and proteasome pathways and Genomics, phytochemicals, and oxidative stress.

Hippo pathway signaling …0Hippo pathway signaling and YAP/TAZ: 0 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksGenomics, phytochemicals, and oxidative stress: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksSynthesis and biological activity: 0 fractional worksAutoimmune Bullous Skin Diseases: 0 fractional works
Cell BiologyGeneticsMolecular BiologyCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hippo pathway signaling and YAP/TAZ Cell Biology 0 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
  3. 3 Ubiquitin and proteasome pathways Molecular Biology 0 works
  4. 4 Genomics, phytochemicals, and oxidative stress Molecular Biology 0 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 0 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  9. 9 Synthesis and biological activity Organic Chemistry 0 works
  10. 10 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.9%not open67.1%

World: 28% of research is openly available.

with international co-authors19.5%domestic only80.5%

World: 19% is written across borders.

How has Principia Biopharma (United States)'s research output changed?

Output in 2018–2022 was 50% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.